Karen Kuphal Ph.D.

Karen Kuphal PhD, MBA, PMP is an accomplished professional in the field of regulatory affairs, currently serving as the Director of Regulatory Affairs at Regeneron since February 2023, focusing on oncology therapeutics. Previous roles include Senior Director of Regulatory Affairs at Rebiotix Inc, where successful approval of a first-in-class microbiome therapy was achieved, and Director of Regulatory Affairs at AstraZeneca, overseeing regulatory science and strategy. Karen's extensive experience also encompasses portfolio management at Bristol-Myers Squibb, project management at Coté Orphan LLC, and product development at Leadiant Biosciences. With earlier experience as Associate Director at Cardinal Health Regulatory Sciences and academic roles at the University of Kansas Medical Center and the University of Missouri-Kansas City, Karen holds multiple degrees, including a PhD in Exercise Physiology and an MBA in Business Analytics from The George Washington University.